Capital Medica Ventures

What Capital Medica Ventures does

Capital Medica Ventures is a Tokyo-based venture capital firm founded in 2016 that focuses on impact investing in healthcare-adjacent and social-issue startups. Its primary vehicle is the Yamato Social Impact Fund, which it operates as a co-General Partner alongside Nanto Capital Partners. The fund targets regional revitalization in Nara Prefecture and the surrounding Yamato region through investments in companies addressing social issues such as aging-population care, local employment, and regional services.

The firm's go-to-market is anchored on a single regional impact thesis rather than a generalist healthcare mandate. It co-sources, co-underwrites, and co-deploys capital with Nanto Capital Partners, and has executed investments in eight companies to date. Capital Medica Ventures maintains ongoing LP and stakeholder communication through published impact reports, with the third edition released in February 2026. The firm was selected by the Cabinet Office from 810 nationwide cases as a 'notable initiative' for regional revitalization, providing government endorsement of its model.

Revenue mechanics are not publicly disclosed. As a co-GP of an impact fund, the firm would be expected to earn management fees on committed/deployed capital and potentially carry on exits, but no AUM, fund size, or fee schedule is provided. The disclosed headcount band is 1-10 employees, consistent with a boutique Japanese VC manager. Operating geographies are confined to the Kansai Region of Japan. Pricing models, distribution channels, and named portfolio-company customers are not publicly disclosed.

Name

Capital Medica Ventures

Legal name

Capital Medica Ventures

Website

https://capimedi.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Capital Medica Ventures is a Tokyo-based venture capital firm (founded 2016) that co-manages the Yamato Social Impact Fund with Nanto Capital Partners, deploying impact capital into companies addressing social issues in Nara Prefecture and the surrounding Yamato region of Japan.

Ownership category

akta.pro rank

Product category

Venture Capital / Impact Investing

NAICS

Other Financial Vehicles (525990), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare Access & Life Sciences Impact Funds (FSANAJAI)

akta.pro secondary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

Keywords

• Venture capital
• Healthcare investments
• Impact investing
• Social impact funds
• Startup funding

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Core offering

Capital Medica Ventures is a venture capital firm that operates as a co-General Partner (co-GP) of the Yamato Social Impact Fund alongside Nanto Capital Partners. The firm deploys capital into startups — primarily healthcare-adjacent and social-impact companies — in Nara Prefecture and the surrounding Yamato region of Japan, and publishes impact reports measuring social outcomes. The fund has executed investments in eight companies and was selected by Japan's Cabinet Office as a notable initiative for regional revitalization.

Product overview

Capital Medica Ventures operates as a co-general partner (co-GP) of the Yamato Social Impact Fund, an impact investing initiative focused on regional revitalization in Nara Prefecture and the Yamato region. The company collaborates with Nanto Capital Partners to identify and invest in companies addressing social issues, providing capital deployment and impact measurement through published impact reports.

Differentiator

Problem solved

Functional benefit

Products and services

• Yamato Social Impact Fund

Quantifiable outcome

• The Yamato Social Impact Fund was selected from 810 cases nationwide as a 'notable initiative' for regional revitalization

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Nanto Capital Partners: Japanese regional investment and consulting firm headquartered in Nara Prefecture. Direct peer because it co-manages the Yamato Social Impact Fund with Capital Medica Ventures and shares the same regional, impact-oriented mandate in the Yamato/Kansai area.
• Yamaguchi Capital Co., Ltd. Yamaguchi Prefecture-affiliated regional venture capital firm that invests in regional startups with revitalisation themes. Comparable to CMV due to its government-linked regional VC mandate and focus on fostering local entrepreneurship outside Japan's major metros.
• Hiroshima Venture Capital (Hirogin Ventures): Regional venture capital firm backed by Hiroshima-area financial institutions, investing in local startups. Comparable as a Japanese regional VC with similar deal sizes, regional revitalisation lens, and corporate-bank sponsorship model.

Broad incumbents

• JAFCO Group: Largest Japanese venture capital firm with broad sector mandates including healthcare and regional investments. Broad incumbent because it operates across stages and geographies, but its healthcare exposure and Japanese LP base make it a comparable reference point for CMV's institutional positioning.
• MUFG Innovation Partners: CVC arm of Mitsubishi UFJ Financial Group investing across stages and sectors in Japan. Relevant as a large Japanese institutional VC with healthcare and impact-aligned activity, providing scale reference for what a mature version of CMV's platform could look like.
• SMBC Venture Capital: Sumitomo Mitsui Banking Corporation's venture capital arm, active across Japanese startup stages and sectors including healthcare. Comparable as a bank-affiliated Japanese VC competing for similar healthcare and impact-adjacent opportunities.
• Daiwa Corporate Investment: Japanese investment firm affiliated with Daiwa Securities, deploying venture and growth capital across Japanese sectors. Relevant as a Japanese institutional alternative-asset investor whose fund-of-funds and direct healthcare activity overlap with CMV's investment universe.

Emerging players

• Real Tech Holdings: Japan-focused deep tech and impact venture firm backing startups in healthcare, energy, and sustainability. Comparable to CMV because it operates at the intersection of impact mandates and science-based sectors in Japan, although Real Tech is larger and pan-regional.

Others

• Social Impact Japan Foundation: Japanese non-profit organisation promoting impact investing and measurement standards. Relevant ecosystem participant because it shapes the LP/regulatory environment for Japanese impact funds like CMV's Yamato Social Impact Fund.

Regional players

• Hokuriku Industrial Advancement Center: Public regional investment body supporting startups in the Hokuriku region of Japan. Comparable as a public-sector regional revitalisation investor operating in a defined Japanese prefecture cluster, similar in mandate to CMV's Yamato focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/capitalmedica-co-ltd-

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments19 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Capital Medica Ventures